Q4 2025 Earnings Call Transcript July 15, 2025 AngioDynamics, Inc. beats earnings expectations. Reported EPS is $-0.03, expectations were $-0.13. Operator: Good morning, and welcome to the ...

AngioDynamics Inc (ANGO) reports a robust 12% revenue increase, driven by Med Tech advancements, despite facing tariff impacts.

A Capital Region manufacturer expects to continue growing its revenue over the next year, though its bottom line could take a ...

AngioDynamics beat on sales and beat on earnings this morning -- sort of. The company reported a smaller-than-expected ...

Gain insights into AngioDynamics' Q4 2025 earnings, highlighting 12% revenue growth, international expansion, Med Tech advances, and a strong FY26 outlook.

The Motley Fool. DATE Tuesday, July 15, 2025 at 8:00 a.m. ET Read More: Earn up to $845 cash back this year just by changing ...

Analysts estimate that AngioDynamics will report an earnings per share (EPS) of $-0.12. Investors in AngioDynamics are eagerly awaiting the company's announcement, hoping for news of surpassing ...

Ablation technology market was valued at US$ 6.82 billion in 2024 and is projected to hit the market valuation of US$ 16.74 billion by 2034 at a CAGR of 9.82% during the forecast period 2025–2034. A ...

The global varicose vein treatment market is estimated to be valued at USD 857.8 million in 2025 and is projected to reach USD 1,594.2 million by 2035, registering a compound annual growth rate of 6.4 ...

The Zacks Momentum Style Score, part of the Zacks Style Scores, helps address this issue for us. Below, we take a look at AngioDynamics (ANGO), which currently has a Momentum Style Score of B. We also ...

AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment ...